Administrative Core
Administrative Core
批准号:
10667436
负责人:
Takahisa Kanekiyo
金额:
$39.18万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-06-01 至 2026-05-31
关键词:
AccountabilityAddressAdministrative PersonnelAdvisory CommitteesAgingAlzheimer&aposs DiseaseApolipoprotein EBiochemicalBioinformaticsBiological ModelsBiologyBiometryClinicCollaborationsCommunitiesComplexDataData SetDedicationsDepartment chairEnsureEventGenotypeGoalsImpaired cognitionIndividualInstitutionInterdisciplinary StudyKnowledgeKnowledge PortalLDL-Receptor Related Protein 1LeadLeadershipNeurologyNeurosciencesPathogenesisPathogenicityPathway interactionsPositioning AttributeProgress ReportsPropertyProtein IsoformsPublicationsQuality ControlReagentRecording of previous eventsReproducibilityResearchResearch PersonnelResource SharingResourcesRiskRoleSiteStructureSystemTherapeuticUnited States National Institutes of HealthUniversitiesWashingtonanalytical methoddata accessdata managementdata sharingdesignexperienceinnovationmedical schoolsmeetingsnervous system disordernovelprogramsprotective effectresearch in practiceresponsible research conductsharing platformsymposiumsynergismweb portalweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY (APOE U19 Core A: Administrative Core)
The Administrative Core will lead this U19 project by providing administrative, fiscal, and scientific oversight
and promoting synergy of all Cores and Projects to address the ApoE Cascade Hypothesis. Core A will serve
several functions to facilitate the scientific objectives and rigor of this U19. It will also serve the broader
scientific community by sharing knowledge, resources, and datasets through a web portal and by promoting
collaboration through an annual ApoE Symposium. Core A will cooperate fully with NIA initiatives with a
dedicated leadership team and administrative personnel with relevant experience. As the Co-PIs of this U19
project and Co-Leaders of Core A, Drs. Guojun Bu (Mayo Clinic Jacksonville) and David Holtzman
(Washington University in St. Louis) are recognized leaders in the apoE field; each has more than 25 years of
experience studying apoE and apoE receptors as they relate to the pathogenesis of AD and other aging-
related conditions. Drs. Bu and Holtzman have a long history of collaboration and are well positioned to share
leadership roles for this U19 program at the two coordinating institutions. They also have strong leadership
experience each serving as a Department Chair and an Associate Director of Alzheimer’s Disease Research
Center at their respective institution. Together with Dr. Alison Goate, who will serve as the Site-PI at Icahn
School of Medicine at Mount Sinai, they will ensure integration and synergy across the U19 by pursuing the
following aims: Aim 1: Provide administrative structure, fiscal oversight, and site coordination for the U19
program. Aim 2: Assume responsibility for the quality control of the U19 activities by ensuring responsible
conduct of research, rigor, and reproducibility of research practices, and by ensuring compliance with all
internal and external regulatory requirements. Promote and track open-access publications and facilitate
submission of progress reports to NIH. Aim 3: Promote the scientific direction and integration of the U19
components by organizing meetings of the Internal Steering Committee and External Advisory Committee. Aim
4: Develop and maintain an apoE website what will serve as knowledge portal, and resource and data sharing
platform. Aim 5: Organize Annual ApoE Symposium for U19 investigators as well as the broader scientific
community to interact and share research findings. These innovative aims will ensure that the robust and
rigorous efforts by the U19 team investigators will lead to new discoveries to inform therapeutic strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuronal ABCA7 loss of function and Alzheimer’s disease
-
批准号:10629715
-
项目类别:
-
资助金额:$206.31万
-
财政年份:2023
-
负责人:Takahisa Kanekiyo
-
依托单位:
Therapeutic Strategy to Treat Alzheimer's Disease by VGF Delivery into Brain
-
批准号:10738951
-
项目类别:
-
资助金额:$60.02万
-
财政年份:2023
-
负责人:Takahisa Kanekiyo
-
依托单位:
Biomarker Core
-
批准号:10667447
-
项目类别:
-
资助金额:$46.37万
-
财政年份:2021
-
负责人:Takahisa Kanekiyo
-
依托单位:
Biomarker Core
-
批准号:10407939
-
项目类别:
-
资助金额:$46.71万
-
财政年份:2021
-
负责人:Takahisa Kanekiyo
-
依托单位:
Enhanced APOE2 Expression into Brain for Therapeutic Strategy for Alzheimer's Disease
-
批准号:10208342
-
项目类别:
-
资助金额:$143.76万
-
财政年份:2021
-
负责人:Takahisa Kanekiyo
-
依托单位:
Enhanced APOE2 Expression into Brain for Therapeutic Strategy for Alzheimer's Disease
-
批准号:10514954
-
项目类别:
-
资助金额:$19.1万
-
财政年份:2021
-
负责人:Takahisa Kanekiyo
-
依托单位:
Impact of vascular apoE in aging and AD
-
批准号:10407947
-
项目类别:
-
资助金额:$54.78万
-
财政年份:2021
-
负责人:Takahisa Kanekiyo
-
依托单位:
Administrative Core
-
批准号:10407936
-
项目类别:
-
资助金额:$39.18万
-
财政年份:2021
-
负责人:Takahisa Kanekiyo
-
依托单位:
Impact of vascular apoE in aging and AD
-
批准号:10667475
-
项目类别:
-
资助金额:$54.78万
-
财政年份:2021
-
负责人:Takahisa Kanekiyo
-
依托单位:
Pathogenic mechanisms of ABCA7 in Alzheimer's disease
-
批准号:9221000
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2017
-
负责人:Takahisa Kanekiyo
-
依托单位:
Apoe based solid nanoparticles for prevention and treatment of Alzheimer's Disease
-
批准号:9519334
-
项目类别:
-
资助金额:$14.5万
-
财政年份:2016
-
负责人:Takahisa Kanekiyo
-
依托单位:
Brain Neurotropic Growth Factor Delivery to Prevent and Treat Alzheimer’s Disease
-
批准号:9170894
-
项目类别:
-
资助金额:$38.81万
-
财政年份:2016
-
负责人:Takahisa Kanekiyo
-
依托单位:
海外基金